- Report
- September 2026
- 192 Pages
Global
From €3289EUR$3,545USD£2,744GBP
€3655EUR$3,939USD£3,049GBP
- Report
- May 2026
- 180 Pages
Global
From €4176EUR$4,500USD£3,483GBP
- Report
- January 2026
- 180 Pages
Global
From €4176EUR$4,500USD£3,483GBP
- Report
- November 2026
- 376 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- November 2026
- 273 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- November 2026
- 376 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- November 2026
- 372 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- November 2026
- 604 Pages
Global
From €5428EUR$5,850USD£4,528GBP
- Report
- July 2026
- 200 Pages
Global
From €7414EUR$7,990USD£6,184GBP
- Report
- July 2026
- 224 Pages
Global
From €7414EUR$7,990USD£6,184GBP
- Report
- July 2026
- 356 Pages
Global
From €7414EUR$7,990USD£6,184GBP
- Report
- July 2026
- 324 Pages
Global
From €7414EUR$7,990USD£6,184GBP
- Report
- July 2026
- 237 Pages
Global
From €7414EUR$7,990USD£6,184GBP
- Report
- July 2026
- 244 Pages
Global
From €7414EUR$7,990USD£6,184GBP
- Report
- April 2026
- 30 Pages
Global
From €2552EUR$2,750USD£2,129GBP
- Report
- December 2025
- 200 Pages
Global
From €7377EUR$7,950USD£6,153GBP
- Report
- August 2026
- 180 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- August 2026
- 110 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- August 2026
- 111 Pages
Global
From €4408EUR$4,750USD£3,677GBP
- Report
- July 2026
- 200 Pages
Global
From €7414EUR$7,990USD£6,184GBP

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones.
The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare.
Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more